BioSpace News Archive

Deals

Salarius Announces Proposed Public Offering of Common Stock - Mar 03, 2021

Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced that it has commenced an underwritten public offering of shares of its common stock.

March 3, 2021
·
3 min read
Deals

Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1

Nephrology portfolio strengthened by expanded US difelikefalin agreement, license for ANG-3777 and EU regulatory submission of avacopan

March 3, 2021
·
16 min read
Biotech Beach

Bionaut Labs Debuts From Stealth Mode to Accelerate Development of New Precision Treatment Modality for Brain Disorders

Bionaut Labs, a company focused on revolutionizing the treatment of central nervous system disorders with its Bionaut™ precision medicine treatment modality, announced its launch backed by $20 million financing led by Khosla Ventures.

March 3, 2021
·
5 min read
Deals

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange

SciClone Pharmaceuticals Limited was officially listed on the Main Board of The Stock Exchange of Hong Kong Limited under stock code: 6600.

March 3, 2021
·
6 min read
ACL Reconstruction Demand Fuelled by Surging Cases of Sports-Related Knee Injuries, Says Fact.MR

Fact.MR, a global research & consulting firm, in their latest edition of the report, reflected that the ACL Reconstruction market is likely to see a moderate growth pace in 2021 and beyond.

March 3, 2021
·
4 min read
Colonic Stents Market: Nitinol Self-expandable Metal Stents Segment to Offer Attractive Opportunities

A colonic stent can be defined as a hollow cylindrical tube that is made up of metal or an alloy which assists to keep the large bowel lumen open.

March 3, 2021
·
5 min read
Epistaxis Devices Market: Increasing Prevalence of Hypertension and Change in Environment to Boost Market

Epistaxis is a condition that results in uncertain nose bleeding from either of the nostrils. This clinical condition is usually classified as posterior epistaxis and anterior epistaxis based on the site where the bleeding originates.

March 3, 2021
·
5 min read
Back-end Revenue Cycle Management Market - Increasing Adoption of Back-End Revenue Cycle Management in the Healthcare Organizations

The healthcare revenue cycle includes multiple independent yet connected segments, starting from registration to claims management, that are separated by front-end and back-end components.

March 3, 2021
·
5 min read
Business

Dignitana expands agreement with GenesisCare to include United States

Dignitana AB, global leader in scalp cooling innovation, announced an agreement signed with GenesisCare to expand their preferred provider network for DigniCap scalp cooling systems to include GenesisCare locations in the United States.

March 3, 2021
·
2 min read
Deals

Cybin Inc. Announces Uplisting to OTCQB Venture Market

Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, announced its successful uplisting from the OTC Pink Sheets to the OTCQB® Venture Market.

March 3, 2021
·
5 min read